Atsttrin

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameAtsttrin
Drug Alias NameN/A
ClassificationBiologics > Protein drugs
Mechanisms of ActionTumor necrosis factor receptor inhibitorsTumor necrosis factor α inhibitors
TargetsTumor necrosis factor receptorTumor necrosis factor α
Therapy Area/IndicationsTendinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNew York University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAtreaon Inc
Active IndicationsN/A
Inactive IndicationsTendinopathy

Other Information

ATC CodeN/A
Related LinksN/A